CN102552388A - 青钱柳胶囊及其制备方法 - Google Patents
青钱柳胶囊及其制备方法 Download PDFInfo
- Publication number
- CN102552388A CN102552388A CN2012100073840A CN201210007384A CN102552388A CN 102552388 A CN102552388 A CN 102552388A CN 2012100073840 A CN2012100073840 A CN 2012100073840A CN 201210007384 A CN201210007384 A CN 201210007384A CN 102552388 A CN102552388 A CN 102552388A
- Authority
- CN
- China
- Prior art keywords
- cyclocarya paliurus
- paliurus iljinskaja
- capsule
- total
- iljinskaja
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000233779 Cyclocarya paliurus Species 0.000 title claims abstract description 164
- 239000002775 capsule Substances 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title abstract description 11
- 239000007901 soft capsule Substances 0.000 claims abstract description 41
- 239000007788 liquid Substances 0.000 claims abstract description 40
- 150000004676 glycans Chemical class 0.000 claims abstract description 38
- 239000007902 hard capsule Substances 0.000 claims abstract description 38
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 38
- 239000005017 polysaccharide Substances 0.000 claims abstract description 38
- 150000003648 triterpenes Chemical class 0.000 claims abstract description 37
- 238000000034 method Methods 0.000 claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 85
- 239000000843 powder Substances 0.000 claims description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 37
- 229960004756 ethanol Drugs 0.000 claims description 26
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 20
- 238000000605 extraction Methods 0.000 claims description 20
- 238000001694 spray drying Methods 0.000 claims description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- 239000007766 cera flava Substances 0.000 claims description 16
- 235000018597 common camellia Nutrition 0.000 claims description 15
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 15
- 108010010803 Gelatin Proteins 0.000 claims description 12
- 239000008273 gelatin Substances 0.000 claims description 12
- 229920000159 gelatin Polymers 0.000 claims description 12
- 235000019322 gelatine Nutrition 0.000 claims description 12
- 235000011852 gelatine desserts Nutrition 0.000 claims description 12
- 238000005303 weighing Methods 0.000 claims description 12
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 10
- 229920000881 Modified starch Polymers 0.000 claims description 10
- 229930003427 Vitamin E Natural products 0.000 claims description 10
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 10
- 230000008021 deposition Effects 0.000 claims description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 10
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 10
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 10
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 10
- 239000002244 precipitate Substances 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- 238000002137 ultrasound extraction Methods 0.000 claims description 10
- 229940046009 vitamin E Drugs 0.000 claims description 10
- 235000019165 vitamin E Nutrition 0.000 claims description 10
- 239000011709 vitamin E Substances 0.000 claims description 10
- 239000002245 particle Substances 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 239000000084 colloidal system Substances 0.000 claims description 6
- 238000000748 compression moulding Methods 0.000 claims description 6
- 238000007872 degassing Methods 0.000 claims description 6
- 239000000945 filler Substances 0.000 claims description 6
- 238000011049 filling Methods 0.000 claims description 6
- 238000009413 insulation Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000009849 vacuum degassing Methods 0.000 claims description 6
- 239000000080 wetting agent Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 3
- 238000010257 thawing Methods 0.000 claims description 2
- 241000209507 Camellia Species 0.000 claims 4
- 239000008280 blood Substances 0.000 abstract description 23
- 210000004369 blood Anatomy 0.000 abstract description 23
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 15
- 238000002474 experimental method Methods 0.000 abstract description 5
- 238000005457 optimization Methods 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 5
- 238000012216 screening Methods 0.000 abstract description 5
- 241001465754 Metazoa Species 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 230000008859 change Effects 0.000 abstract description 2
- 239000007771 core particle Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 29
- 241000699670 Mus sp. Species 0.000 description 22
- 229920002527 Glycogen Polymers 0.000 description 17
- 229940096919 glycogen Drugs 0.000 description 17
- 210000004153 islets of langerhan Anatomy 0.000 description 15
- 210000004923 pancreatic tissue Anatomy 0.000 description 12
- 240000001548 Camellia japonica Species 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 230000002440 hepatic effect Effects 0.000 description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 230000037396 body weight Effects 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 6
- 239000013641 positive control Substances 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- 241000124033 Salix Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 229940023488 pill Drugs 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 3
- 229960001052 streptozocin Drugs 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000233778 Cyclocarya Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940046011 buccal tablet Drugs 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000013118 diabetic mouse model Methods 0.000 description 1
- 239000012502 diagnostic product Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 235000020344 instant tea Nutrition 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000004132 lipogenesis Effects 0.000 description 1
- 230000006680 metabolic alteration Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
助悬效果 | 流动性 | 沉降比 | |
配比制囊芯液前 | 分层 | 差 | 0.81 |
配比制囊芯液后 | 稳定 | 较好 | 1 |
休止角 | 吸湿率(环境湿度为75%) | |
制粒前青钱柳原料粉 | 43.2° | 26.36% |
制粒后的颗粒 | 30.1° | 4.58% |
血糖值mmol/L | 体重/g | |
正常对照组 | 6.5±0.7 | 28.4±1.9 |
模型对照组 | 32.4±0.9 | 18.2±1.6 |
阳性对照组 | 8.8±7.0** | 26.4±1.3** |
胶囊高剂量组 | 12.4±3.8** | 23.8±2.7** |
胶囊中剂量组 | 16.4±8.6* | 20.7±2.2* |
胶囊低剂量组 | 17.3±7.1* | 21.7±1.7** |
总胆固醇mmol/L | 甘油三酯mmol/L | |
正常对照组 | 2.075±0.248 | 1.456±0.462 |
模型对照组 | 3.311±0.565 | 1.245±0.436 |
阳性对照组 | 2.453±0.432** | 1.428±0.120 |
胶囊高剂量组 | 2.479±0.490** | 1.309±0.380 |
胶囊中剂量组 | 2.703±0.452* | 1.191±0.396 |
胶囊低剂量组 | 2.918±0.644 | 1.566±0.434 |
糖原含量(mg/g) | |
正常对照组 | 2.514±0.241 |
模型对照组 | 1.837±0.342 |
阳性对照组 | 2.105±0.169 |
胶囊高剂量组 | 2.949±0.612** |
胶囊中剂量组 | 2.305±0.172** |
胶囊低剂量组 | 2.155±0.142* |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100073840A CN102552388B (zh) | 2012-01-11 | 2012-01-11 | 青钱柳胶囊及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100073840A CN102552388B (zh) | 2012-01-11 | 2012-01-11 | 青钱柳胶囊及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102552388A true CN102552388A (zh) | 2012-07-11 |
CN102552388B CN102552388B (zh) | 2013-07-03 |
Family
ID=46399844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012100073840A Expired - Fee Related CN102552388B (zh) | 2012-01-11 | 2012-01-11 | 青钱柳胶囊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102552388B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104940282A (zh) * | 2015-06-05 | 2015-09-30 | 百花医花集团股份有限公司 | 一种青钱柳制剂及其制备方法 |
CN105054202A (zh) * | 2015-08-28 | 2015-11-18 | 江西万茂科技有限公司 | 青钱柳草本植物饮料及制作工艺 |
WO2016173509A1 (en) * | 2015-04-29 | 2016-11-03 | Infinitus (China) Company Ltd | Compositions comprising cyclocarya paliurus extract and preparation method and uses thereof |
EP3108754A1 (en) * | 2015-06-24 | 2016-12-28 | Analyticon Discovery GmbH | Novel triterpene glycosides as sweeteners or sweetener enhancer |
CN109364119A (zh) * | 2018-12-26 | 2019-02-22 | 浙江大学 | 从青钱柳叶中制备具有降血糖作用的总三萜的方法及应用 |
CN109452622A (zh) * | 2018-11-15 | 2019-03-12 | 江苏康缘药业股份有限公司 | 一种复方灵芝孢子粉及其制备方法 |
CN111329928A (zh) * | 2020-03-24 | 2020-06-26 | 遵义医科大学珠海校区 | 一种含山茶油的组合物及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101244119A (zh) * | 2008-02-04 | 2008-08-20 | 广西师范大学 | 从青钱柳提取多糖及有效成分的方法 |
-
2012
- 2012-01-11 CN CN2012100073840A patent/CN102552388B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101244119A (zh) * | 2008-02-04 | 2008-08-20 | 广西师范大学 | 从青钱柳提取多糖及有效成分的方法 |
Non-Patent Citations (4)
Title |
---|
上官新晨等: "超声波法提取青钱柳多糖", 《江西农业大学学报》, vol. 28, no. 06, 31 December 2006 (2006-12-31) * |
尹忠平等: "超声辅助提取青钱柳叶总三萜化合物研究", 《江西农业大学学报》, vol. 32, no. 02, 28 February 2010 (2010-02-28) * |
李磊等: "青钱柳多糖降血糖作用研究", 《中药材》, vol. 25, no. 01, 31 January 2002 (2002-01-31) * |
谢建华等: "青钱柳多糖提取工艺的研究", 《食品科学》, vol. 28, no. 10, 31 October 2007 (2007-10-31) * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10413580B2 (en) | 2015-04-29 | 2019-09-17 | Infinitus (China) Company Ltd | Compositions comprising Cyclocarya paliurus extract and preparation method and uses thereof |
WO2016173509A1 (en) * | 2015-04-29 | 2016-11-03 | Infinitus (China) Company Ltd | Compositions comprising cyclocarya paliurus extract and preparation method and uses thereof |
US10111923B2 (en) | 2015-04-29 | 2018-10-30 | Infinitus (China) Company Ltd | Compositions comprising Cyclocarya paliurus extract and preparation method and uses thereof |
CN104940282A (zh) * | 2015-06-05 | 2015-09-30 | 百花医花集团股份有限公司 | 一种青钱柳制剂及其制备方法 |
EP3108754A1 (en) * | 2015-06-24 | 2016-12-28 | Analyticon Discovery GmbH | Novel triterpene glycosides as sweeteners or sweetener enhancer |
WO2016207001A1 (en) * | 2015-06-24 | 2016-12-29 | Analyticon Discovery Gmbh | Novel triterpene-glycosides as sweeteners or sweetener enhancer |
CN108235686A (zh) * | 2015-06-24 | 2018-06-29 | 阿纳里蒂科探索有限责任公司 | 新型三萜苷作为甜味剂或甜味增强剂 |
CN105054202A (zh) * | 2015-08-28 | 2015-11-18 | 江西万茂科技有限公司 | 青钱柳草本植物饮料及制作工艺 |
CN109452622A (zh) * | 2018-11-15 | 2019-03-12 | 江苏康缘药业股份有限公司 | 一种复方灵芝孢子粉及其制备方法 |
CN109364119A (zh) * | 2018-12-26 | 2019-02-22 | 浙江大学 | 从青钱柳叶中制备具有降血糖作用的总三萜的方法及应用 |
CN109364119B (zh) * | 2018-12-26 | 2021-10-01 | 浙江大学 | 从青钱柳叶中制备具有降血糖作用的总三萜的方法及应用 |
CN111329928A (zh) * | 2020-03-24 | 2020-06-26 | 遵义医科大学珠海校区 | 一种含山茶油的组合物及其应用 |
CN111329928B (zh) * | 2020-03-24 | 2022-01-14 | 遵义医科大学珠海校区 | 一种含山茶油的组合物及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102552388B (zh) | 2013-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102552388B (zh) | 青钱柳胶囊及其制备方法 | |
CN102525945B (zh) | 青钱柳降血糖冲剂的制备方法 | |
RU2362578C1 (ru) | Лекарственный препарат для лечения сахарного диабета и метод его приготовления | |
CN104383123A (zh) | 一种金花茶降脂降糖制剂的制备方法 | |
CN109549971A (zh) | 一种调节高血糖的功能性食品及其制备方法 | |
CN102058757A (zh) | 一种治疗心血管疾病的中药组合物及其制备方法 | |
CN102961596B (zh) | 一种用于治疗糖尿病的中药组合物及其制备方法和应用 | |
CN102389454B (zh) | 一种复方白背三七降血糖制剂及其制备方法 | |
US20140127334A1 (en) | Drug compound for the control of blood glucose, blood lipids and weight | |
CN105341893A (zh) | 一种辅助降血糖的组合物及应用 | |
CN100577158C (zh) | 藤茶素分散片的制备方法及用途 | |
CN102319357B (zh) | 一种降脂灵分散片及其制备工艺 | |
CN101849950A (zh) | 救必应酸在制备调血脂的药物中的应用 | |
CN113730464A (zh) | 香连丸及其提取物、药物组合物与香连丸产物的新用途 | |
CN102579530A (zh) | 具有抗糖尿病作用的太白楤木总皂苷的制备方法及药物 | |
WO2006122454A1 (fr) | Composition pharmaceutique pour le traitement du diabete et son procede de preparation | |
CN102441064B (zh) | 用于治疗糖尿病的中药组合物及其制剂 | |
CN101554406A (zh) | 桑树皮降糖药用活性物质提取工艺及其配方 | |
CN109223811A (zh) | 具有降糖活性的人参皂苷组合物 | |
CN101708307A (zh) | 一种用于治疗乳腺增生的药物及其制法 | |
CN105876036A (zh) | 一种降血糖泡腾片凉茶及其制备方法 | |
CN101263900B (zh) | 玉米花丝软胶囊的制备方法 | |
CN101219200A (zh) | 一种中药软胶囊及其制备方法 | |
CN104056020B (zh) | 一种治疗代谢综合征的中药组合物 | |
CN102363017A (zh) | 一种用于清热解毒、活血化瘀、利湿化痰的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120711 Assignee: Guizhou Leishan Lao Ni Qing Qianliu Development Co.,Ltd. Assignor: Nanjing Forestry University Contract record no.: 2018320000351 Denomination of invention: Cyclocarya paliurus capsule and preparation method thereof Granted publication date: 20130703 License type: Common License Record date: 20181127 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130703 |
|
CF01 | Termination of patent right due to non-payment of annual fee |